about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...
Read More
0.96
0.01
(1.05%)
217.6K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..